Target intelligence / Profile preview

Nociceptor (nociceptive nerve fiber)

Molecular classification
Other (Sensory neuron; not a single molecular entity), Ion channel (TRPV1, TRPA1, ASICs, others involved in nociception), Receptor (e.g., TRPV1, TRPA1 for specific fiber subtypes)
01

Overview

Nociceptors, commonly referred to as pain fibers, are specialized primary sensory neurons that detect and transmit signals from noxious thermal, mechanical, or chemical stimuli to the central nervous system. They exist as heterogeneous populations, including myelinated Aδ fibers (mediate sharp, immediate “first pain”) and unmyelinated C fibers (mediate dull, delayed “second pain”). These fibers express various transducer proteins and ion channels such as TRPV1 (the capsaicin/vanilloid receptor), TRPA1, and acid-sensing ion channels (ASICs), which enable them to respond to a broad range of noxious stimuli[1][2][3][4]. Neuropeptides like CGRP and substance P are released from nociceptors and play roles in inflammation and pain amplification. As an anatomical/phenotypic entity rather than a molecular one, "pain fibers" do not represent a single therapeutic target, but components expressed by these fibers (such as TRPV1) are pursued as discrete drug targets in pain management[1][2][3].

Other names
pain fiberpain nerve fibersensory fiber (in the context of pain)nociceptive fiberprimary afferent nociceptor
02

Mechanism of action

Blockade or desensitization of specific ion channels (e.g., TRPV1 antagonism by certain drugs); Inhibition of action potential propagation (local anesthetics inhibiting voltage-gated sodium channels); Modulation of neurotransmitter/neuropeptide release

03

Biological functions

Nociception (pain sensing)Signal transductionNeurotransmissionInflammatory response (via neuropeptide release)
04

Disease associations

Pain (acute and chronic)InflammationNeuropathic painOther (pruritus/itch, hyperalgesia, allodynia, etc.)
05

Safety considerations

Nonspecific targeting can lead to loss of essential pain perception (risk of unnoticed injury)Differential expression and function in humans vs animals complicate translation of therapiesPotential for sensory deficits, numbness, or dysesthesia with excessive inhibition
06

Interacting drugs

Capsaicin (TRPV1 agonist/desensitizer)

5 more in the full profile.

07

Biomarkers

Expression of TRPV1, TRPA1, P2X3, Nav1.7/Nav1.8 sodium channels in nerve tissueNeuropeptides: Substance P, calcitonin gene-related peptide (CGRP)

Beyond the preview

Go deeper on Nociceptor (nociceptive nerve fiber).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nociceptor (nociceptive nerve fiber).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call